San Francisco, CA, United States of America

Melissa Teran

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melissa Teran: Innovator in Machine Learning for Ovarian Stimulation

Introduction

Melissa Teran is a pioneering inventor based in San Francisco, CA, who has made significant contributions to the field of reproductive health through her innovative work in machine learning. Her research focuses on optimizing ovarian stimulation processes, which can greatly enhance the outcomes for patients undergoing fertility treatments.

Latest Patents

Melissa Teran holds a patent for her invention titled "Machine learning for optimizing ovarian stimulation." This patent describes systems and methods for implementing machine-learning models to improve ovarian stimulation. The computer-implemented method involves receiving patient-specific data and predicting egg outcomes for various treatment options based on predictive models trained with prior patient data. This innovative approach aims to personalize and enhance the ovarian stimulation process for better patient outcomes.

Career Highlights

Melissa is currently associated with Alife Health Inc., where she applies her expertise in machine learning to advance reproductive health technologies. Her work is instrumental in developing solutions that leverage data to improve fertility treatments.

Collaborations

Throughout her career, Melissa has collaborated with notable colleagues, including Kevin Loewke and Paxton H Maeder-York. These partnerships have contributed to the advancement of her research and the development of innovative solutions in the field.

Conclusion

Melissa Teran is a remarkable inventor whose work in machine learning is transforming the landscape of ovarian stimulation and fertility treatments. Her contributions are paving the way for more effective and personalized healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…